US20040067532A1
(en)
|
2002-08-12 |
2004-04-08 |
Genetastix Corporation |
High throughput generation and affinity maturation of humanized antibody
|
WO2005019255A1
(en)
*
|
2003-08-25 |
2005-03-03 |
Pieris Proteolab Ag |
Muteins of tear lipocalin
|
CA2565701A1
(en)
|
2004-05-06 |
2005-11-17 |
Jonathan M. Barasch |
Ngal for reduction and amelioration of ischemic and nephrotoxic injuries
|
EP2899277A1
(de)
|
2004-11-26 |
2015-07-29 |
Pieris AG |
Verbindung mit Affinität für das zytotoxische T-Lymphozyten-assoziierte Antigen (CTLA-4)
|
DK1831699T3
(da)
*
|
2004-12-20 |
2010-03-15 |
Antibodyshop As |
Bestemmelse af neutrofil gelatine-associeret lipocalin (NGAL) som en diagnostisk markør for nyresygdomme
|
US7611847B2
(en)
|
2005-06-01 |
2009-11-03 |
Agency For Science, Technology And Research |
Method for identifying an intestinal phenotype
|
BRPI0621413A2
(pt)
|
2006-02-13 |
2011-12-06 |
Agency Science Tech & Res |
método de processamento de uma amostra biológica e/ou quìmica
|
US8261598B2
(en)
|
2006-03-09 |
2012-09-11 |
Agency For Science, Technology And Research |
Apparatus for performing a reaction in a droplet and method of using the same
|
ATE539351T1
(de)
|
2006-05-30 |
2012-01-15 |
Antibodyshop As |
Verfahren zur schnellen beurteilung der schwere eines traumas
|
CA2659413C
(en)
|
2006-08-01 |
2016-06-14 |
Pieris Ag |
Muteins of tear lipocalin and methods for obtaining the same
|
JP2010500535A
(ja)
*
|
2006-08-07 |
2010-01-07 |
アンチボディショップ・アクティーゼルスカブ |
重大な腎損傷を除外するための診断検査
|
BRPI0719597A2
(pt)
|
2006-11-22 |
2013-12-17 |
Adnexus A Bristol Myers Squibb R & D Company |
Produtos terapêuticos objetivados baseados em proteínas manipuladas para receptores de quinases de tirosina, incluindo igf-ir
|
WO2008063135A1
(en)
|
2006-11-24 |
2008-05-29 |
Agency For Science, Technology And Research |
Apparatus for processing a sample in a liquid droplet and method of using the same
|
US9874501B2
(en)
|
2006-11-24 |
2018-01-23 |
Curiox Biosystems Pte Ltd. |
Use of chemically patterned substrate for liquid handling, chemical and biological reactions
|
WO2008113363A1
(en)
|
2007-03-21 |
2008-09-25 |
Bioporto Diagnostics A/S |
Diagnostic test for renal injury
|
US8663915B2
(en)
|
2007-04-13 |
2014-03-04 |
Agency For Science, Technology And Research |
Methods of controlling tumorigenesis and diagnosing the risk thereof
|
WO2008136769A1
(en)
|
2007-05-03 |
2008-11-13 |
Nanyang Technological University |
Online contaminant detection and removal system
|
AU2008281913B2
(en)
*
|
2007-07-31 |
2013-11-07 |
Affibody Ab |
New albumin binding compositions, methods and uses
|
SG150405A1
(en)
|
2007-08-29 |
2009-03-30 |
Agency Science Tech & Res |
Method of coating a particle
|
BRPI0816785A2
(pt)
|
2007-09-14 |
2017-05-02 |
Adimab Inc |
bibliotecas de anticorpos sintéticos racionalmente desenhadas, e, usos para as mesmas
|
US8877688B2
(en)
|
2007-09-14 |
2014-11-04 |
Adimab, Llc |
Rationally designed, synthetic antibody libraries and uses therefor
|
JP2011501673A
(ja)
*
|
2007-10-19 |
2011-01-13 |
アボット・ラボラトリーズ |
グリコシル化された哺乳動物ngal及びその使用
|
US20090269777A1
(en)
*
|
2007-10-19 |
2009-10-29 |
Abbott Laboratories |
Immunoassays and kits for the detection of ngal
|
US20090176274A1
(en)
*
|
2007-10-19 |
2009-07-09 |
Abbott Laboratories |
Glycosylated mammalian ngal and use thereof
|
US8846036B2
(en)
|
2007-10-19 |
2014-09-30 |
Abbott Laboratories |
Antibodies that bind to mammalian NGAL and uses thereof
|
US20090123946A1
(en)
*
|
2007-10-19 |
2009-05-14 |
Abbott Laboratories |
Immunoassays and kits for the detection of ngal
|
US20090123970A1
(en)
*
|
2007-10-19 |
2009-05-14 |
Abbott Laboratories |
Glycosylated mammalian ngal and use thereof
|
US20090124022A1
(en)
*
|
2007-10-19 |
2009-05-14 |
Abbott Laboratories |
Antibodies that bind to mammalian ngal and uses thereof
|
US8969313B2
(en)
|
2007-11-02 |
2015-03-03 |
Agency For Science, Technology And Research |
Methods and compounds for preventing and treating a tumour
|
US10725020B2
(en)
|
2007-11-14 |
2020-07-28 |
Curiox Biosystems Pte Ltd. |
High throughput miniaturized assay system and methods
|
WO2013114217A1
(en)
|
2012-02-05 |
2013-08-08 |
Curiox Biosystems Pte Ltd. |
Array plates and methods for making and using same
|
ES2475990T5
(es)
*
|
2007-11-15 |
2017-07-06 |
Bioporto Diagnostics A/S |
Uso diagnóstico de formas moleculares individuales de un biomarcador
|
US20090274623A1
(en)
*
|
2008-01-30 |
2009-11-05 |
General Electric Company |
In vivo imaging agents for met receptor tyrosine kinase
|
JP2011522520A
(ja)
|
2008-05-06 |
2011-08-04 |
エージェンシー フォー サイエンス,テクノロジー アンド リサーチ |
細胞の脱分化を行う方法
|
EP2300045A1
(de)
|
2008-05-15 |
2011-03-30 |
Transmolecular, Inc. |
Behandlung von metastatischen tumoren
|
JP2011520961A
(ja)
|
2008-05-22 |
2011-07-21 |
ブリストル−マイヤーズ スクイブ カンパニー |
多価フィブロネクチンをベースとする足場ドメインタンパク質
|
AU2009264214B2
(en)
*
|
2008-06-24 |
2013-06-06 |
Technische Universitaet Muenchen |
Muteins of hNGAL and related proteins with affinity for a given target
|
AU2013224694B2
(en)
*
|
2008-06-24 |
2015-09-10 |
Technische Universitaet Muenchen |
MUTEINS OF hNGAL AND RELATED PROTEINS WITH AFFINITY FOR A GIVEN TARGET
|
EP2321405A4
(de)
|
2008-08-08 |
2012-09-12 |
Agency Science Tech & Res |
Mikrofluidikvorrichtung mit kontinuierlichem durchfluss
|
US8716420B2
(en)
|
2008-10-13 |
2014-05-06 |
Agency For Science, Technology And Research |
Amphiphilic polymers and nanocrystals coated therewith
|
ATE523603T1
(de)
|
2008-11-21 |
2011-09-15 |
Chimera Biotec Gmbh |
Konjugatkomplexe zum analytnachweis
|
US10464811B2
(en)
|
2009-04-06 |
2019-11-05 |
Nanyang Technological University |
Method of forming a particulate porous metal oxide or metalloid oxide
|
US8784752B2
(en)
|
2009-04-17 |
2014-07-22 |
Curiox Biosystems Pte Ltd |
Use of chemically patterned substrate for liquid handling, chemical and biological reactions
|
CN102549427A
(zh)
|
2009-07-07 |
2012-07-04 |
新加坡科技研究局 |
鉴定结合配偶体对的方法
|
CN106139123A
(zh)
|
2009-08-05 |
2016-11-23 |
爱力根公司 |
脂质运载蛋白突变蛋白的控制释放制剂
|
EP3660510A3
(de)
*
|
2009-12-07 |
2020-07-08 |
Pieris Pharmaceuticals GmbH |
Muteine von humanem lipocalin 2 (lcn2, hngal) mit affinität für ein bestimmtes zielmolekül
|
US9689801B2
(en)
|
2009-12-22 |
2017-06-27 |
Agency For Science, Technology And Research |
SERS-based analyte detection
|
CA2788824C
(en)
|
2010-02-04 |
2019-03-12 |
Morphotek, Inc. |
Chlorotoxin polypeptides and conjugates and uses thereof
|
WO2011123061A1
(en)
|
2010-03-31 |
2011-10-06 |
Agency For Science, Technology And Research |
Amphiphilic linear peptide/peptoid and hydrogel comprising the same
|
CN103097403B
(zh)
|
2010-05-11 |
2017-04-19 |
弗雷德哈钦森癌症研究中心 |
氯毒素变体、缀合物及其使用方法
|
WO2011149962A1
(en)
|
2010-05-24 |
2011-12-01 |
The Trustees Of Columbia University In The City Of New York |
Mutant ngal proteins and uses thereof
|
CN105949301B
(zh)
|
2010-06-08 |
2020-03-27 |
皮里斯制药有限公司 |
结合IL-4受体α的泪脂质运载蛋白突变蛋白
|
US9878328B2
(en)
|
2010-07-23 |
2018-01-30 |
Curiox Biosystems Pte Ltd. |
Apparatus and method for multiple reactions in small volumes
|
WO2012022742A1
(en)
*
|
2010-08-16 |
2012-02-23 |
Pieris Ag |
Binding proteins for hepcidin
|
US8987415B2
(en)
|
2010-09-07 |
2015-03-24 |
Technische Universitaet Muenchen |
Recombinant bacterial lipocalin blc and uses thereof
|
JP6100694B2
(ja)
|
2010-11-15 |
2017-03-22 |
ピエリス ファーマシューティカルズ ゲーエムベーハー |
グリピカン−3(gpc3)に対して親和性を有するヒトリポカリン2の突然変異タンパク質
|
SG190727A1
(en)
|
2010-11-30 |
2013-07-31 |
Chugai Pharmaceutical Co Ltd |
Antigen-binding molecule capable of binding to plurality of antigen molecules repeatedly
|
US9221885B2
(en)
|
2010-12-02 |
2015-12-29 |
Pieris Ag |
Muteins of human lipocalin 2 with affinity for CTLA-4
|
EP2698431B1
(de)
|
2011-03-30 |
2020-09-09 |
Chugai Seiyaku Kabushiki Kaisha |
Aufrechterhaltung antigenbindender moleküle im blutplasma und verfahren zur modifizierung einer immunogenität
|
WO2012136685A1
(en)
|
2011-04-04 |
2012-10-11 |
Pieris Ag |
Methods and compositions for anti-vegf and anti-c-met therapy
|
US9556281B2
(en)
|
2011-08-15 |
2017-01-31 |
The University Of Chicago |
Compositions and methods related to antibodies to staphylococcal protein A
|
CA3186007A1
(en)
|
2011-09-30 |
2013-04-04 |
Chugai Seiyaku Kabushiki Kaisha |
Ion concentration-dependent binding molecule library
|
KR102366029B1
(ko)
|
2011-09-30 |
2022-02-23 |
추가이 세이야쿠 가부시키가이샤 |
표적 항원에 대한 면역응답을 유도하는 항원 결합 분자
|
TWI827333B
(zh)
|
2011-09-30 |
2023-12-21 |
日商中外製藥股份有限公司 |
促進抗原消失的抗原結合分子
|
EP2765192A4
(de)
|
2011-10-05 |
2015-04-15 |
Chugai Pharmaceutical Co Ltd |
Antigenbindendes molekül zur herstellung eines abstands zwischen einem plasma und einem antigen mit einer saccharidkettenrezeptor-bindenden domäne
|
AU2012325013A1
(en)
|
2011-10-17 |
2014-03-27 |
Westfaelische Wilhelms-Universitaet Muenster |
Methods of risk assessment of PML and related apparatus
|
EP3517550A1
(de)
|
2011-11-30 |
2019-07-31 |
Chugai Seiyaku Kabushiki Kaisha |
Arzneimittelhaltiger träger in zellen zur bildung eines immunkomplexes
|
AU2012350654C1
(en)
|
2011-12-12 |
2018-05-10 |
Pieris Ag |
Methods for preventing or treating disorders by increasing bioavailability of iron and related pharmaceutical formulation
|
DK3453400T3
(da)
|
2011-12-13 |
2021-04-06 |
Pieris Pharmaceuticals Gmbh |
Fremgangsmåder til forebyggelse eller behandling af visse forstyrrelser ved inhibering af binding af il-4 og/eller il-13 til deres respektive receptorer
|
JP6420664B2
(ja)
|
2012-01-09 |
2018-11-14 |
ピエリス ファーマシューティカルズ ゲーエムベーハー |
障害を予防、処置、または診断するための方法
|
US9758554B2
(en)
|
2012-01-31 |
2017-09-12 |
Technische Universitaet Muenchen |
Muteins of α1m lipocalin and method of production therefor
|
CN106940268B
(zh)
|
2012-02-23 |
2021-09-21 |
朱诺治疗有限公司 |
细胞和其它复杂生物材料的色谱分离
|
KR102219987B1
(ko)
|
2012-02-24 |
2021-02-25 |
추가이 세이야쿠 가부시키가이샤 |
FcγRIIB를 매개로 항원의 소실을 촉진하는 항원 결합 분자
|
EP2647995B8
(de)
|
2012-04-02 |
2015-02-18 |
Roche Diagnostics GmbH |
Verfahren und Anwendung zur Beurteilung der Schwere einer chronisch obstruktiven Lungenerkrankung (COPD)
|
EP2841101B1
(de)
|
2012-04-26 |
2019-08-07 |
University Of Chicago |
Zusammensetzungen und verfahren in zusammenhang mit antikörpern zur neutralisierung der koagulaseaktivität bei einer staphylococcus-aureus-erkrankung
|
CA2871160C
(en)
|
2012-05-10 |
2023-03-14 |
Massachusetts Institute Of Technology |
Agents for influenza neutralization
|
WO2013174783A1
(en)
|
2012-05-23 |
2013-11-28 |
Pieris Ag |
Lipocalin muteins with binding-affinity for glypican-3 (gpc-3) and use of lipocalin muteins for target-specific delivery to cells expressing gpc-3
|
JPWO2013180200A1
(ja)
|
2012-05-30 |
2016-01-21 |
中外製薬株式会社 |
標的組織特異的抗原結合分子
|
EP2857419B1
(de)
|
2012-05-30 |
2021-01-13 |
Chugai Seiyaku Kabushiki Kaisha |
Antigenbindende moleküle zur beseitigung von aggregierten antigenen
|
WO2013189521A1
(en)
|
2012-06-19 |
2013-12-27 |
Waclawczyk Simon |
Method of generating cells of hepatocyte phenotype
|
EP2687850A1
(de)
|
2012-07-19 |
2014-01-22 |
Roche Diagniostics GmbH |
Verfahren zur Stratifizierung für Atemunterstützungstherapie
|
AU2013299986B2
(en)
|
2012-08-07 |
2018-05-17 |
Massachusetts Institute Of Technology |
Anti-dengue virus antibodies and uses thereof
|
US10179178B2
(en)
|
2012-08-27 |
2019-01-15 |
Nanyang Technology University |
Nanoparticulate contrast agent
|
CN104662043B
(zh)
|
2012-09-10 |
2019-10-18 |
明斯特大学 |
用于预防、治疗和诊断炎性病症的方法和化合物
|
US9096840B2
(en)
|
2012-10-04 |
2015-08-04 |
Research Development Foundation |
Serine protease molecules and therapies
|
EP3441400B1
(de)
|
2012-11-19 |
2022-07-20 |
Pieris Pharmaceuticals GmbH |
Neuartige polypeptide mit spezifischer bindung und verwendungen davon
|
EP2925337B1
(de)
|
2012-11-21 |
2019-07-03 |
The Trustees of Columbia University in the City of New York |
Mutante ngal-proteine und verwendungen davon
|
CN105189540A
(zh)
*
|
2012-12-10 |
2015-12-23 |
弗莱德哈钦森癌症研究中心 |
含脂质运载蛋白融合伴侣
|
CN105246503A
(zh)
|
2013-03-14 |
2016-01-13 |
第一三共株式会社 |
Pcsk9的新颖结合蛋白
|
EP2972387A1
(de)
|
2013-03-15 |
2016-01-20 |
Westfälische Wilhelms-Universität Münster |
Nachweis von akuter renaler allotransplantatabstossung
|
ES2935257T3
(es)
|
2013-03-15 |
2023-03-03 |
Univ Chicago |
Métodos y composiciones relacionadas con la actividad de las células T
|
WO2014163101A1
(ja)
|
2013-04-02 |
2014-10-09 |
中外製薬株式会社 |
Fc領域改変体
|
WO2014197723A2
(en)
|
2013-06-05 |
2014-12-11 |
Massachusetts Institute Of Technology |
Human adaptation of h7 ha
|
CA2916694C
(en)
|
2013-06-28 |
2023-01-17 |
Baylor Research Institute |
Dendritic cell asgpr targeting immunotherapeutics for multiple sclerosis
|
US9557318B2
(en)
|
2013-07-09 |
2017-01-31 |
Curiox Biosystems Pte Ltd. |
Array plates for washing samples
|
NZ746944A
(en)
|
2013-07-23 |
2021-07-30 |
Biocon Ltd |
Use of a cd6 binding partner and method based thereon
|
CA2921401A1
(en)
|
2013-08-14 |
2015-02-19 |
William Marsh Rice University |
Derivatives of uncialamycin, methods of synthesis and their use as antitumor agents
|
US11559580B1
(en)
|
2013-09-17 |
2023-01-24 |
Blaze Bioscience, Inc. |
Tissue-homing peptide conjugates and methods of use thereof
|
WO2015078711A2
(en)
|
2013-11-18 |
2015-06-04 |
Westfaelische Wilhelms-Universitaet Muenster |
Methods, peptides and antibodies for preventing, treating and diagnosing an inflammatory condition
|
JP7060317B2
(ja)
|
2013-12-04 |
2022-04-26 |
中外製薬株式会社 |
化合物の濃度に応じて抗原結合能の変化する抗原結合分子及びそのライブラリ
|
CA2936611A1
(en)
|
2014-01-13 |
2015-07-16 |
Pieris Pharmaceuticals Gmbh |
Multi-specific polypeptide useful for localized tumor immunomodulation
|
JP7037884B2
(ja)
|
2014-01-13 |
2022-03-17 |
ベイラー リサーチ インスティテュート |
Hpv及びhpv関連疾患に対する新規のワクチン
|
AU2015217149B2
(en)
|
2014-02-11 |
2020-09-10 |
Massachusetts Institute Of Technology |
Novel full spectrum anti-dengue antibody
|
LU92409B1
(en)
|
2014-03-21 |
2015-09-22 |
Philipps Universit T Marburg |
Means and methods for itaconic acid production
|
MY184699A
(en)
|
2014-04-16 |
2021-04-18 |
Juno Therapeutics Gmbh |
Methods, kits and apparatus for expanding a population of cells
|
CN106662584B
(zh)
|
2014-04-30 |
2020-05-05 |
Iba股份有限公司 |
分离靶细胞的方法
|
BR112016027024A2
(pt)
|
2014-05-22 |
2017-10-31 |
Pieris Pharmaceuticals Gmbh |
polipeptídeos de ligação específica e seus usos
|
MA41022A
(fr)
|
2014-11-24 |
2017-10-03 |
Shire Human Genetic Therapies |
Ciblage lysosomial et utilisations correspondantes
|
US10526382B2
(en)
|
2015-01-28 |
2020-01-07 |
Pieris Pharmaceuticals Gmbh |
Human neutrophil gelatinase-associated lipocalin (hNGAL) muteins capable of binding angiopoietin-2 (Ang-2) and methods of use thereof
|
TW202248212A
(zh)
|
2015-02-05 |
2022-12-16 |
日商中外製藥股份有限公司 |
包含離子濃度依賴之抗原結合域的抗體、Fc區變體、IL-8結合抗體與其用途
|
EP3064507A1
(de)
|
2015-03-06 |
2016-09-07 |
Deutsches Krebsforschungszentrum Stiftung des öffentlichen Rechts |
Fusionsproteine mit einem bindenden Protein und einem Interleukin-15-Polypeptid mit reduzierter Affinität für IL15ra und therapeutische Verwendungen davon
|
WO2016166568A1
(en)
|
2015-04-16 |
2016-10-20 |
Juno Therapeutics Gmbh |
Methods, kits and apparatus for expanding a population of cells
|
AU2016258977C1
(en)
|
2015-05-04 |
2022-07-14 |
Pieris Pharmaceuticals Gmbh |
Anti-cancer fusion polypeptide
|
US11261221B2
(en)
|
2015-05-04 |
2022-03-01 |
Pieris Pharmaceuticals Gmbh |
Proteins specific for CD137
|
CN108112253B
(zh)
|
2015-05-18 |
2022-09-23 |
皮里斯制药有限公司 |
抗癌融合多肽
|
CN107787327B
(zh)
|
2015-05-18 |
2022-02-08 |
皮里斯制药有限公司 |
对磷脂酰肌醇聚糖-3(gpc3)具有亲和力的人脂质运载蛋白2的突变蛋白
|
US10545139B2
(en)
|
2015-06-16 |
2020-01-28 |
Curiox Biosystems Pte Ltd. |
Methods and devices for performing biological assays using magnetic components
|
EP3115371A1
(de)
|
2015-07-07 |
2017-01-11 |
Sanofi |
Fusionsmoleküle
|
PE20181336A1
(es)
|
2015-09-18 |
2018-08-21 |
Chugai Pharmaceutical Co Ltd |
Anticuerpos que se unen a interleucina 8 (il-8) y sus usos
|
MA45489A
(fr)
|
2015-10-22 |
2018-08-29 |
Juno Therapeutics Gmbh |
Procédés de culture de cellules, kits et appareil associés
|
MA45488A
(fr)
|
2015-10-22 |
2018-08-29 |
Juno Therapeutics Gmbh |
Procédés, kits et appareil de culture de cellules
|
RU2021134624A
(ru)
|
2015-10-22 |
2022-03-15 |
Джуно Терапьютикс Гмбх |
Способы, наборы, средства и устройства для трансдукции
|
BR112018010887A2
(pt)
*
|
2015-11-30 |
2018-11-21 |
Pieris Australia Pty Ltd |
polipeptídeo de fusão
|
TW201725212A
(zh)
|
2015-12-10 |
2017-07-16 |
第一三共股份有限公司 |
特異性於降鈣素基因相關胜肽的新穎蛋白
|
WO2017143026A1
(en)
|
2016-02-16 |
2017-08-24 |
Research Development Foundation |
Sortase-modified molecules and uses thereof
|
WO2017175200A1
(en)
|
2016-04-08 |
2017-10-12 |
The Regents Of The University Of California |
Modified hyaluronic acid hydrogels and proteins for the time-controlled release of biologic agents
|
WO2018087108A1
(en)
|
2016-11-09 |
2018-05-17 |
Pieris Pharmaceuticals Gmbh |
Proteins specific for cd137
|
EP3546574A4
(de)
|
2016-11-28 |
2020-09-09 |
Chugai Seiyaku Kabushiki Kaisha |
Antigenbindende domänen und polypeptid mit förderabschnitt
|
KR102533814B1
(ko)
|
2016-11-28 |
2023-05-19 |
추가이 세이야쿠 가부시키가이샤 |
리간드 결합 활성을 조정 가능한 리간드 결합 분자
|
EP3571219A1
(de)
|
2017-01-18 |
2019-11-27 |
Pieris Pharmaceuticals GmbH |
Lipocalin-muteine mit bindungsaffinität für lag-3
|
WO2018185554A1
(en)
|
2017-04-05 |
2018-10-11 |
Curiox Biosystems Pte Ltd. |
Methods, devices, and apparatus for washing samples on array plates
|
KR102606210B1
(ko)
|
2017-04-27 |
2023-11-24 |
주노 테라퓨틱스 게엠베하 |
올리고머 입자 시약 및 이의 사용 방법
|
WO2018202471A1
(en)
|
2017-05-02 |
2018-11-08 |
Bayer Aktiengesellschaft |
Tmem16a modulation for diagnostic or therapeutic use in pulmonary hypertension (ph)
|
KR20200074201A
(ko)
|
2017-11-02 |
2020-06-24 |
바이엘 악티엔게젤샤프트 |
Alk-1 및 bmpr-2에 결합하는 이중특이적 항체
|
CA3083259A1
(en)
|
2017-11-28 |
2019-06-06 |
Chugai Seiyaku Kabushiki Kaisha |
Polypeptide including antigen-binding domain and carrying section
|
JP7266532B2
(ja)
|
2017-11-28 |
2023-04-28 |
中外製薬株式会社 |
リガンド結合活性が調整可能なリガンド結合分子
|
WO2019244973A1
(ja)
|
2018-06-20 |
2019-12-26 |
中外製薬株式会社 |
標的細胞に対する免疫反応を活性化する方法およびその組成物
|
WO2019243564A1
(en)
|
2018-06-21 |
2019-12-26 |
Technische Universitaet Muenchen |
Hepatitis b and/or hepatitis d-permissive cells and animals
|
KR102259473B1
(ko)
|
2018-08-10 |
2021-06-02 |
추가이 세이야쿠 가부시키가이샤 |
항cd137 항원 결합 분자 및 그의 사용
|
WO2020043693A1
(en)
|
2018-08-29 |
2020-03-05 |
Westfälische Wilhelms-Universität Münster |
Diagnosis of multiple sclerosis
|
DE102018124022A1
(de)
|
2018-09-28 |
2020-04-02 |
Rheinisch-Westfälische Technische Hochschule (Rwth) Aachen |
Hyaluronsäurestabilisator
|
JP2022512872A
(ja)
|
2018-10-31 |
2022-02-07 |
ジュノ セラピューティクス ゲーエムベーハー |
細胞の選択および刺激のための方法ならびにそのための装置
|
EP3930687A4
(de)
|
2019-02-25 |
2023-06-07 |
The University of Chicago |
Verfahren und zusammensetzungen zur behandlung von entzündungs- und autoimmunzuständen mit ecm-affinitätspeptiden, die mit entzündungshemmenden mitteln verbunden sind
|
EP3943108A4
(de)
|
2019-03-19 |
2023-01-04 |
Chugai Seiyaku Kabushiki Kaisha |
Antigen-bindendes molekül mit antigen-bindender domäne mit veränderlicher bindungsaktivität gegenüber antigen in abhängigkeit von mta und bibliothek zur gewinnung der antigen-bindenden domäne
|
EP3946417A1
(de)
|
2019-03-29 |
2022-02-09 |
Pieris Pharmaceuticals GmbH |
Inhalierte verabreichung von lipocalin-muteinen
|
WO2020200960A1
(en)
|
2019-03-29 |
2020-10-08 |
Astrazeneca Ab |
Lipocalin mutein for treatment of asthma
|
CA3134705A1
(en)
|
2019-04-02 |
2020-10-08 |
Chugai Seiyaku Kabushiki Kaisha |
Method of introducing target-specific foreign gene
|
CN114206355A
(zh)
|
2019-06-03 |
2022-03-18 |
芝加哥大学 |
用靶向癌症的佐剂治疗癌症的方法和组合物
|
KR20220017430A
(ko)
|
2019-06-05 |
2022-02-11 |
추가이 세이야쿠 가부시키가이샤 |
항체 절단 부위 결합 분자
|
JPWO2020246567A1
(de)
|
2019-06-05 |
2020-12-10 |
|
|
CN114008713A
(zh)
|
2019-06-07 |
2022-02-01 |
中外制药株式会社 |
信息处理系统、信息处理方法、程序、以及制备抗原结合分子或蛋白质的方法
|
TW202128160A
(zh)
|
2019-10-18 |
2021-08-01 |
美國加利福尼亞大學董事會 |
用於治療病原性血管病症之方法及組合物
|
AU2020377043A1
(en)
|
2019-10-30 |
2022-06-02 |
Juno Therapeutics Gmbh |
Cell selection and/or stimulation devices and methods of use
|
EP4054718A1
(de)
|
2019-11-04 |
2022-09-14 |
Pieris Pharmaceuticals GmbH |
Her2/4-1bb-bispezifische fusionsproteine zur behandlung von krebs
|
CN115666594A
(zh)
|
2019-11-29 |
2023-01-31 |
苏州诺沃泰医药科技有限公司 |
Cart细胞在制备治疗癌症的药物中的应用
|
WO2021152178A1
(en)
|
2020-01-31 |
2021-08-05 |
Cell.Copedia GmbH |
Methods of isolating a biological entity
|
TW202144395A
(zh)
|
2020-02-12 |
2021-12-01 |
日商中外製藥股份有限公司 |
用於癌症之治療的抗cd137抗原結合分子
|
CN116194124A
(zh)
|
2020-07-31 |
2023-05-30 |
中外制药株式会社 |
包含表达嵌合受体的细胞的药物组合物
|
WO2022072560A1
(en)
*
|
2020-09-30 |
2022-04-07 |
Encodia, Inc. |
Polypeptide terminal binders and uses thereof
|
AU2022210371A1
(en)
|
2021-01-22 |
2023-07-20 |
Bayer Aktiengesellschaft |
Lrrc15 antibodies and conjugates thereof
|
KR20230160366A
(ko)
|
2021-03-23 |
2023-11-23 |
피어이스 파마슈티컬즈 게엠베하 |
암 치료를 위한 her2/4-1bb 이중특이적 융합 단백질
|
WO2022207748A1
(en)
|
2021-03-30 |
2022-10-06 |
Westfälische Wilhelms-Universität Münster |
Classification of neurological or psychiatric disease manifestations using multi-dimensional cerebrospinal fluid analysis
|
CN117916256A
(zh)
|
2021-05-06 |
2024-04-19 |
朱诺治疗学有限公司 |
用于刺激和转导t细胞的方法
|
WO2022243341A1
(en)
|
2021-05-18 |
2022-11-24 |
Pieris Pharmaceuticals Gmbh |
Lipocalin muteins with binding affinity for ox40
|
EP4342984A1
(de)
|
2021-05-19 |
2024-03-27 |
Chugai Seiyaku Kabushiki Kaisha |
Verfahren zur vorhersage der in-vivo-pharmazekinetik eines moleküls
|
WO2023017115A1
(en)
|
2021-08-11 |
2023-02-16 |
Iba Lifesciences Gmbh |
Fractionation of cells based on a marker protein
|
WO2024028794A1
(en)
|
2022-08-02 |
2024-02-08 |
Temple Therapeutics BV |
Methods for treating endometrial and ovarian hyperproliferative disorders
|